Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse. Issue 1 (10th December 2017)

• Record Type: Journal Article
• Authors: Clemenceau, Alisson; Bérubé, Jean‐Christophe; Bélanger, Paméla; Gaudreault, Nathalie; Lamontagne, Maxime; Toubal, Oumhani; Clavel, Marie‐Annick; Capoulade, Romain; Mathieu, Patrick; Pibarot, Philippe; Bosse, Yohan
• Is Part Of: Molecular genetics & genomic medicine. Volume 6:Issue 1(2018)
• Page Start: 114
• Page End: 120
• Publication Date: 2017-12-10
• Subjects: DCHS1 -- deleterious variants -- genetics -- mitral valve prolapse -- sequencing; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.347
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: A recent study identified DCHS1 as a causal gene for mitral valve prolapse. The goal of this study is to investigate the presence and frequency of known and novel variants in this gene in 100 asymptomatic patients with moderate to severe organic mitral regurgitation. Methods: DNA sequencing assays were developed for two previously identified functional missense variants, namely p.R2330C and p.R2513H, and all 21 exons of DCHS1 . Pathogenicity of variants was evaluated in silico. Results: p.R2330C and p.R2513H were not identified in this cohort. Sequencing all coding regions revealed eight missense variants including six considered deleterious. This includes one novel variant (p.A2464P) and two rare variants (p.R2770Q and p.R2462Q). These variants are predicted to be deleterious with combined annotation‐dependent depletion (CADD) scores greater than 25, which are in the same range as p.R2330C (CADD = 28.0) and p.R2513H (CADD = 24.3). More globally, 24 of 100 cases were carriers of at least one in silico‐predicted deleterious missense variant in DCHS1, suggesting that this single gene may account for a substantial portion of cases. Conclusion: This study reveals an important contribution of germline variants in DCHS1 in unrelated patients with mitral valve prolapse and supports genetic testing of this gene to screen individuals at risk. Abstract : Loss‐of‐function variants in the DCHS1 gene were recently identified to segregate with mitral valve prolapse in three families. In this study, we reported rare and novel mutations predicted as similarly deleterious in 100 sporadic cases of mitral valve prolapse. The enrichment of in silico‐predicted deleterious variants in these cases supports the role of DCHS1 in the disease pathogenesis and highlights the importance of germline mutations in this gene to cause or increase disease susceptibility in sporadic cases.